Kim Czubaruk, JD

Experience

• 

  Food Allergy and Anaphylaxis Network; Independent Consultant

  Jan 1996 - Jun 2011

  Legal Consultant, Disability Law

  Advised the Food Allergy and Anaphylaxis Network (FAAN) on the applicability of the Americans with Disabilities Act of 1990 (ADA), the Rehabilitation Act of 1973, and the Individuals with Disabilities Education Act (IDEA). Engaged members of Congress, state legislators, regulators, and researchers to secure policies and advance the science for individuals with food anaphylaxis. Advocated for passage of the Food Allergen and Labeling Consumer Protection Act and testified before the FDA Food Advisory Committee. Successfully lobbied for changes to Virginia's licensing requirements for child daycare centers. Advised attorneys nationwide on causes of action for individuals diagnosed with food anaphylaxis. Prepared and presented educational materials to public and private sectors including businesses, school systems, health departments, camps, and childcare centers. Served as spokesperson with national and regional media, published articles, and presented at national conferences. Show less

• 

  Heterogeneity-llc

  Jul 2011 - Feb 2019

  Consultant

  Collaborated with team members to address regulatory issues and product development strategies for biologics, prescription drugs, and foods (dietary supplements and foods for special dietary uses) on behalf of domestic and international manufacturers. Prepared and managed FDA Investigational New Drug Applications (INDA) and New Drug Applications (NDA).

• 

  American Academy of Nursing

  Jun 2012 - Feb 2019

  Policy Manager

  Advised the Academy on federal and state legislation, regulations, and trends influencing health policy. Prepared policy briefs, position statements, and comment letters on issues regarding the Patient Protection and Affordable Care Act (ACA), Medicare, Medicaid, women's health, LGBTQA, mental health, veterans' health, maternal and infant health, aging, substance use and addiction, palliative care, social determinants of health, and health equity. Advanced Academy priorities with the Eldercare Workforce Alliance, the Veterans Health Council of Vietnam Veterans of America, the National Partnership for Women & Families Women's Health Defense Table, Partnership to Improve Patient Care (PIPC), The National Association of State Directors of Veterans Affairs (NASDVA), and the National Council of Juvenile and Family Court Judges. Developed and executed the Academy's signature veterans' health campaign Have You Ever Served in the Military?. Led the Academy’s advocacy in support of Mayors Against Illegal Guns. Identified and advocated for innovative models of care to members of Congress, state policy makers, providers, payers, and hospital systems through strategic leadership of the Academy's Edge Runner initiative. Show less

• 

  Cancer Support Community

  Mar 2019 - Sept 2022

  Senior Director, Policy and Advocacy, Cancer Policy Institute

  Lead in the development and implementation of CSC’s regulatory and legislative agenda. Serve as the primary author of comments, memos, briefs, letters, and other documents to federal agencies (e.g., FDA, CMS, NCI), members of Congress, governors, and state legislators regarding coverage (including Medicare, Medicaid, ACA), access, quality, affordability, value, copay accumulators, telehealth, utilization management, drug development, PDUFA, equity, diversity, and inclusion. Advocate for patient-centered policies with Congressional offices, industry, federal departments and agencies, providers, payers, and patient advocacy organizations. Regularly engage with sponsors and secure funding for CSC's studies, summits, meetings, and sustaining policy activities. Seek innovative patient-centered utilization management through multi-stakeholder roundtables. Provide leadership as a steering committee member of the All Copays Count Coalition and Partnership for Part D Access, and as a member of the Cancer Leadership Council, Patient Quality of Life Coalition (PQLC), Chronic Illness and Disability Partnership (CIDP), Coalition to Improve Access to Cancer Care (CIACC), CAR-T Working Group, Value in the States Coalition, and Clinical Trials Implementation Barriers Workgroup. Draft Cures 2.0 Act legislative language. Plan and effectuate CSC's Externally-Led Patient-Focused Drug Development Meeting on Cancer Cachexia. Design and execute CSC's Exploring Patient-Centered Endpoints Summit including writing and dissemination of the Final Report. Initiate and lead CSC's study Examining the Cost of Step Therapy: An Analysis of Commercial Claims Data to Determine the Cost Burden to the System and Patients. Disseminate methodology and results of CSC's work with the goal of influencing national and state policies and practices. Show less

• 

  CancerCare

  Sept 2022 - now

  Oversee the direction of CancerCare's advocacy efforts through developing and implementing strategic branding, cultivating alliances within the oncology community, and advancing the organization's national policy agenda to ensure equal access to quality, safe, affordable, and comprehensive cancer treatment.Design, develop, and lead complex multi-disciplinary projects; engage with federal and state legislators and regulatory agencies; prepare written and oral comments; establish collaborative relationships with cancer stakeholders and the broader health community; help secure funding for programs; represent CancerCare at meetings and forums to increase awareness and support key initiatives. Show less

  • Associate Vice President of Policy

    Jul 2023 - now

  • Senior Director, Strategy and Policy

    Sept 2022 - Jul 2023